TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...
Q4 2025 Earnings Call February 11, 2026 4:30 PM ESTCompany ParticipantsChad Fugure - Vice President of Investor ...
Hinge Health, Inc. (NYSE:HNGE) Q4 2025 Earnings Call Transcript February 10, 2026 Hinge Health, Inc. beats earnings expectations. Reported EPS is $0.3797, expectations were $0.04. Operator: Ladies and ...
Neurocrine Biosciences, Inc. ( NBIX) Q4 2025 Earnings Call February 11, 2026 4:30 PM EST ...
Thank you, operator, and thank you all for joining PolyPid's Fourth Quarter and Full Year 2025 Earnings Conference Call.
I’m a practicing clinical psychologist, and over the past year, I have begun using a conversational AI tool as part of my ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results